Cargando…

Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events

The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elasfar, Abdelfatah, Jalali, Kafaf, Hussein, Mohamed, AlHarbi, Ibraheem, Amoudi, Osama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035384/ https://www.ncbi.nlm.nih.gov/pubmed/29989026 http://dx.doi.org/10.1016/j.jsha.2017.12.002

Ejemplares similares

Endovascular repair of severe aortic coarctation, transcatheter aortic valve replacement for severe aortic stenosis, and percutaneous coronary intervention in an elderly patient with long term follow-up
por: Fallatah, Raneem, et al.
Publicado: (2018)

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
por: van den Bergh, Walter M., et al.
Publicado: (2015)

Successful Pediatric Mechanical Thrombectomy for HeartMate 3-Related Intracranial Thromboembolism
por: Proulx, Catherine, et al.
Publicado: (2022)

Long-Term Withdrawal of Anticoagulation and Antiplatelet Therapy in a HeartMate 3 Left Ventricular Assist Device
por: Menchaca, Kristina, et al.
Publicado: (2022)

Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation
por: Damman, Kevin, et al.
Publicado: (2022)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Intraoperative pump thrombosis (PT) in HeartMate (HM) III
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device
por: Capoccia, Massimo, et al.
Publicado: (2013)

Accuracy of Doppler blood pressure measurement in HeartMate 3 ventricular assist device patients
por: Li, Song, et al.
Publicado: (2020)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

HeartMate III as a Bridge to Transplantation in an Adolescent With Failed Fontan Circulation
por: Marey, Gamal, et al.
Publicado: (2019)

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
por: Akin, S., et al.
Publicado: (2015)

Validation of non‐invasive ramp testing for HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2020)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2021)

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Six‐month outcomes in postapproval HeartMate3 patients: A single‐center US experience
por: Bansal, Aditya, et al.
Publicado: (2022)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
por: Balceniuk, Mark D., et al.
Publicado: (2020)

Initial Canadian Experience With Bilateral Minithoracotomy Approach for HeartMate 3 Left Ventricular Assist Device Implantation
por: Vasanthan, Vishnu, et al.
Publicado: (2019)

Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022)

Inflow cannula position as risk factor for stroke in patients with HeartMate 3 left ventricular assist devices
por: Schlöglhofer, Thomas, et al.
Publicado: (2022)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration
por: Adamson, Robert M, et al.
Publicado: (2015)

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion
por: Medina, Melissa, et al.
Publicado: (2023)

HeartMate 3 biventricular support exceeding 4.5 years
por: Gasparovic, Hrvoje, et al.
Publicado: (2023)

High fidelity computational simulation of thrombus formation in Thoratec HeartMate II continuous flow ventricular assist device
por: Wu, Wei-Tao, et al.
Publicado: (2016)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
por: Numan, Lieke, et al.
Publicado: (2023)

Correlation between plasma N-terminal probrain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement
por: Elasfar, Abdelfatah
Publicado: (2012)

Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
por: Hayashi, Hideyuki, et al.
Publicado: (2021)

Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer
por: Butt, Nausharwan, et al.
Publicado: (2023)

Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023)

MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device
por: Nguyen Thanh, Hien Kiem, et al.
Publicado: (2015)

Analysis Paralysis: Transition to HeartMate 3 Left Ventricular Assist Device Despite Multiple Complications from COVID-19
por: BhatiaPatel, S., et al.
Publicado: (2022)

Human Factors Evaluation of HeartMate 3 Left Ventricular Assist Device Peripherals: An Eye Tracking Supported Simulation Study
por: Widhalm, Gregor, et al.
Publicado: (2023)

Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
por: Schweiger, Martin, et al.
Publicado: (2023)

Twisting and constriction of a HeartMate II driveline in the area of a repair site
por: Maier, Sven, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uouiel6etvuse7o2dr58cifda6